Personalized Medicine in Cystic Fibrosis
A genetic disease called cystic fibrosis results from mutations in the
gene that codes for a protein called CFTR, which regulates the body’s
ability to absorb and secrete salts and water[30]. The drug is
designed to target one of several faulty CFTR proteins in patients,
resulting in meaningful and long-term improvements in lung function
[31].
Personalized medicine in the COVID-19
In the ongoing global pandemic of Corona virus, personalized medicine is
currently being utilized to aid in the prevention of its spread.
Scientists are now utilizing artificial intelligence and the automated
patient model to identify COVID-19 high-risk genes.
Several studies are studying whether Corona virus can be treated with
drugs designed for other diseases. COVID-19 patients who suffer
complications such as sepsis might benefit from these drugs as they can
be used to develop new clinical strategies to improve their survival
rates. In patients with serious COVID-19 reactions, data-driven
observations aid in the identification and characterization of
underlying and related disorders, as well as problems related to such
conditions.